HOME
BUSINESS SUMMARY
BACKGROUND
PRODUCTS & SERVICES
CLIENT OPPORTUNITIES
MANAGEMENT TEAM
LINKS & DOCUMENTS
ENQUIRIES
CONTACT US

More IML Related News

9th December 2009

EU equivalent of the US Personalised Medicine Coalition, to be known as European PErsonalised MEdicine Diagnostics (EPEMED), kicks off under leadership of Alain Huriez

19th October 2009

Eddie Blair co-chairing Day 2 of the SMI conference on point-of-care diagnostic technologies

19th October 2009

IML attending the fifth annual Harvard Partners personalised medicine conference in Boston on 18th November

19th October 2009

DxS Ltd acquired by QIAGEN GmbH for US$ 95 million to create personalised healthcare vehicle

19th October 2009

£1.6 million Grand Challenge grant from Research Councils UK to fund targeted tumour ablation by magnetic particles

17th July 2009

UK House of Lords supportive of personalised medicines

17th July 2009

Eddie Blair’s CRFocus interview on Innovative Medicines now published

17th July 2009

IML contributing to US Personalized Medicine Coalition recommendations to FDA on companion diagnostics

17th July 2009

IML presentation to The British Pharmaceutical Conference 2009 (6th - 9th September, Manchester) on pharmacogenetic testing confirmed for Day 3

19th May 2009

Integrated Medicines participating in two exciting new projects - wound care diagnostics with ITI Scotland... ...and novel HCV replication inhibitors with Astex Therapeutics

19th May 2009

IML will be presenting on valuation of companion diagnostics at the inaugural SMi In Vitro Diagnostics Conference on 4th June 2009

19th May 2009

IML will be attending ERBI’s 11th BioPartnering Exchange at the Wellcome Trust Genome Campus, Cambridge UK, on 10th – 12th June 2009

19th May 2009

Eddie Blair’s article on the EU Innovative Medicines Initiative will appear in the July issue of CR Focus

19th May 2009

The Academy of Medical Sciences has just released (11th May) its report on a workshop on Global Health Diagnostics

16th April 2009

AACC Oak Ridge conference on the future technologies for diagnostic testing takes place week 16th & 17th April

16th April 2009

IML sponsored conference of biomarkers for personalised medicine takes place on 23rd April

16th April 2009

IML is participating, with BIVDA, ABPI and other organisation on Pillar 1 activities [stratified medicines] as part of new Office for Life Sciences (OLS) initiative under Lord Drayson. IML is also participating in joint AdvaMed/ EDMA initiative on personalised medicines.

16th April 2009

Comprehensive and rapid diagnosis of respiratory viral infections nears completion of relevant panel

9th March 2009

IML sponsors 4th International Conference on Pathway Medicine - Biomarkers in Personalised Medicine Edinburgh, 23rd April 2009

6th March 2009

Massachusetts General Hospital Starts Personalized Cancer Program, others to follow in US and UK

2nd March 2009

IML to present at Visiongain Conference on Biomarkers, London 18th March 2009

23rd February 2009

Low-cost sequencing makes whole genome analysis and personalised medicines more feasible

25th June 2008

IML presents personalised medicine business models to European Diagnostics Manufacturers Association (EDMA) 'Theranostics' Strategic Committee Meeting in Brussels

20th June 2008

AAAS Conference on Personalized Medicine

12th June 2008

IML chairs discussion at Cambridge University Technology and Enterprise Conference or personalised medicines

2nd June 2008

Presentation at ASCO indicates that companion testing aids Erbitux patients selection

2nd June 2008

FDA recognises biomarker information as key component of submissions

29th May 2008

Edinburgh University introduces MSc in Translational Medicine

21st May 2008

Genetic Information Non-disclosure Act of 2008 (GINA) enters US Public Law 110-233

15th May 2008

Nature Biotech article asks “Is personalized medicine finally arriving?"

3rd February 2008

Eddie Blair co-authors of Nature Medicine paper on hICAM1 transgenic mice that can be infected by human common cold virus